Literature DB >> 18385078

Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.

Tomas S Aleman1, Artur V Cideciyan, Alexander Sumaroka, Elizabeth A M Windsor, Waldo Herrera, D Alan White, Shalesh Kaushal, Anjani Naidu, Alejandro J Roman, Sharon B Schwartz, Edwin M Stone, Samuel G Jacobson.   

Abstract

PURPOSE: To determine the underlying retinal micropathology in subclasses of autosomal dominant retinitis pigmentosa (ADRP) caused by rhodopsin (RHO) mutations.
METHODS: Patients with RHO-ADRP (n = 17, ages 6-73 years), representing class A (R135W and P347L) and class B (P23H, T58R, and G106R) functional phenotypes, were studied with optical coherence tomography (OCT), and colocalized visual thresholds were determined by dark- and light-adapted chromatic perimetry. Autofluorescence imaging was performed with near-infrared light. Retinal histology in hT17M-rhodopsin mice was compared with the human results.
RESULTS: Class A patients had only cone-mediated vision. The outer nuclear layer (ONL) thinned with eccentricity and was not detectable within 3 to 4 mm of the fovea. Scotomatous extracentral retina showed loss of ONL, thickening of the inner retina, and demelanization of RPE. Class B patients had superior-inferior asymmetry in function and structure. The superior retina could have normal rod and cone vision, normal lamination (including ONL) and autofluorescence of the RPE melanin; laminopathy was found in the scotomas. With Fourier-domain-OCT, there was apparent inner nuclear layer (INL) thickening in regions with ONL thinning. Retinal regions without ONL had a thick hyporeflective layer that was continuous with the INL from neighboring regions with normal lamination. Transgenic mice had many of the laminar abnormalities found in patients.
CONCLUSIONS: Retinal laminar abnormalities were present in both classes of RHO-ADRP and were related to the severity of colocalized vision loss. The results in human class B and the transgenic mice support the following disease sequence: ONL diminution with INL thickening; amalgamation of residual ONL with the thickened INL; and progressive retinal remodeling with eventual thinning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385078      PMCID: PMC3179264          DOI: 10.1167/iovs.07-1110

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  61 in total

1.  Retinal rod photoreceptor-specific gene mutation perturbs cone pathway development.

Authors:  E Banin; A V Cideciyan; T S Alemán; R M Petters; F Wong; A H Milam; S G Jacobson
Journal:  Neuron       Date:  1999-07       Impact factor: 17.173

2.  Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa.

Authors:  S G Jacobson; K Yagasaki; W J Feuer; A J Román
Journal:  Exp Eye Res       Date:  1989-05       Impact factor: 3.467

3.  Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Alexander Sumaroka; Sharon B Schwartz; Elaine E Smilko; Ann H Milam; Val C Sheffield; Edwin M Stone
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

4.  'Who is the ideal candidate?': decisions and issues relating to visual neuroprosthesis development, patient testing and neuroplasticity.

Authors:  Lotfi B Merabet; Joseph F Rizzo; Alvaro Pascual-Leone; Eduardo Fernandez
Journal:  J Neural Eng       Date:  2007-02-26       Impact factor: 5.379

5.  Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats.

Authors:  T S Aleman; M M LaVail; R Montemayor; G Ying; M M Maguire; A M Laties; S G Jacobson; A V Cideciyan
Journal:  Vision Res       Date:  2001-09       Impact factor: 1.886

6.  Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa.

Authors:  James W Kijas; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Susan E Pearce-Kelling; Brian J Miller; Samuel G Jacobson; Gustavo D Aguirre; Gregory M Acland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

7.  Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations.

Authors:  Eliot L Berson; Bernard Rosner; Carol Weigel-DiFranco; Thaddeus P Dryja; Michael A Sandberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

8.  Regional distribution of retinal degeneration in patients with the proline to histidine mutation in codon 23 of the rhodopsin gene.

Authors:  E M Stone; A E Kimura; B E Nichols; P Khadivi; G A Fishman; V C Sheffield
Journal:  Ophthalmology       Date:  1991-12       Impact factor: 12.079

9.  Rhodopsin mutations in autosomal dominant retinitis pigmentosa.

Authors:  C H Sung; C M Davenport; J C Hennessey; I H Maumenee; S G Jacobson; J R Heckenlively; R Nowakowski; G Fishman; P Gouras; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Histologic study of retinitis pigmentosa due to a mutation in the RP13 gene (PRPC8): comparison with rhodopsin Pro23His, Cys110Arg, and Glu181Lys.

Authors:  King To; Michael Adamian; Eliot L Berson
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

View more
  67 in total

1.  Layer-specific blood-flow MRI of retinitis pigmentosa in RCS rats.

Authors:  Guang Li; Bryan De La Garza; Yen-Yu I Shih; Eric R Muir; Timothy Q Duong
Journal:  Exp Eye Res       Date:  2012-06-18       Impact factor: 3.467

2.  Cone degeneration following rod ablation in a reversible model of retinal degeneration.

Authors:  Rene Y Choi; Gustav A Engbretson; Eduardo C Solessio; Georgette A Jones; Adam Coughlin; Ilija Aleksic; Michael E Zuber
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

3.  The transition zone between healthy and diseased retina in patients with retinitis pigmentosa.

Authors:  Donald C Hood; Margot A Lazow; Kirsten G Locke; Vivienne C Greenstein; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

4.  Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model.

Authors:  Tomas S Aleman; Artur V Cideciyan; Geoffrey K Aguirre; Wei Chieh Huang; Cristina L Mullins; Alejandro J Roman; Alexander Sumaroka; Melani B Olivares; Frank F Tsai; Sharon B Schwartz; Luk H Vandenberghe; Maria P Limberis; Edwin M Stone; Peter Bell; James M Wilson; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

5.  Cone photoreceptor packing density and the outer nuclear layer thickness in healthy subjects.

Authors:  Toco Y P Chui; Hongxin Song; Christopher A Clark; Joel A Papay; Stephen A Burns; Ann E Elsner
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-14       Impact factor: 4.799

6.  Proceedings of the First International Optogenetic Therapies for Vision Symposium.

Authors:  Peter J Francis; Brian Mansfield; Stephen Rose
Journal:  Transl Vis Sci Technol       Date:  2013-11-21       Impact factor: 3.283

7.  Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Igor V Peshenko; Alexander Sumaroka; Elena V Olshevskaya; Lihui Cao; Sharon B Schwartz; Alejandro J Roman; Melani B Olivares; Sam Sadigh; King-Wai Yau; Elise Heon; Edwin M Stone; Alexander M Dizhoor
Journal:  Hum Mol Genet       Date:  2012-10-03       Impact factor: 6.150

8.  Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations.

Authors:  Wei Chieh Huang; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Rebecca Sheplock; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 9.  Promising and delivering gene therapies for vision loss.

Authors:  Livia S Carvalho; Luk H Vandenberghe
Journal:  Vision Res       Date:  2014-08-02       Impact factor: 1.886

10.  Cobalamin C Deficiency Shows a Rapidly Progressing Maculopathy With Severe Photoreceptor and Ganglion Cell Loss.

Authors:  Lucas Bonafede; Can H Ficicioglu; Leona Serrano; Grace Han; Jessica I W Morgan; Monte D Mills; Brian J Forbes; Stefanie L Davidson; Gil Binenbaum; Paige B Kaplan; Charles W Nichols; Patrick Verloo; Bart P Leroy; Albert M Maguire; Tomas S Aleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.